UBI Pharma Inc. – 10/14/2025
Similar Posts
Resource Capacity Planning and Modernized Time Reporting
FDA is making optimal use of its financial resources to maximize its ability to efficiently and effectively deliver on its commitments to the public.Early Alert: Medline Kits May Contain Recalled Medtronic Cardiac Cannulas
Medline is recalling certain Medline Kits containing recalled Medtronic DLP Left Heart Vent Catheters as the catheter may not retain its shape.Biopreventative Company LLC dba Biopreventative – 09/09/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetOver-The-Counter Monograph Drug User Fee Program (OMUFA)
A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potential funding mechanism to supplement congressional non user-fee appropriations.Olympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles
CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching duringZen Enterprises LLC – 678407 – 09/11/2024
Failure to Register and List
